Non-enhanced MRI in combination with color Doppler flow imaging for improving diagnostic accuracy of parotid gland lesions
- 28 Downloads
To determine the value of non-enhanced MRI in combination with color Doppler flow imaging (CDFI) for differentiating malignant parotid tumors from benign ones.
This retrospective study analyzed 51 parotid gland lesions (39 benign and 12 malignant) in 51 patients who underwent preoperative CDFI as well as non-enhanced MRI including T1-weighted, T2-weighted, and diffusion-weighted imaging (DWI). Degrees of intratumor vascularity were categorized into four grades basing on CDFI findings. The relationships between the lesion and its adjacent external carotid artery and retromandibular vein were inspected on T1-weighted and T2-weighted images. Apparent diffusion coefficient (ADC) values were calculated from diffusion-weighted images, and were used to classify the parotid gland lesions with and without reference to the CDFI findings. The classification results were compared using the McNemar test. Sensitivity, specificity, and accuracy percentages were calculated when the non-enhanced MRI/CDFI findings were used to differentiate benign lesions from malignant ones.
The diagnostic accuracy (96.1 vs 82.4%) was significantly improved when ADCs were used together with CDFI findings for classifying parotid gland lesions compared to when ADCs were used alone. Pleomorphic adenomas had the highest ADCs. The ADC thresholds were 1.425 × 10−3 mm2/s for differentiating pleomorphic adenomas from carcinomas, 0.999 × 10−3 mm2/s for differentiating pleomorphic adenomas from other benign lesions, and 0.590 × 10−3 mm2/s for differentiating benign lesions other than pleomorphic adenomas from lymphomas.
Combining CDFI with non-enhanced MRI can improve the diagnostic accuracy of MRI for classifying parotid gland lesions.
KeywordsDiffusion weighted imaging Color Doppler flow imaging Apparent diffusion coefficient Parotid gland lesions
This work was supported by International Communication of Guangxi Medical University Graduate Education, for which the authors are very grateful. We are very grateful to the editor and reviewers.
Compliance with ethical standards
Conflict of interest
All authors declare that there are no conflicts of interests. None bears any financial relationship with the sponsoring organization.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- 3.Lima RA, Tavares MR, Dias FL, Kligerman J, Nascimento MF, Barbosa MM, Cernea CR, Soares JR, Santos IC, Salviano S (2005) Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg 133(5):702–708. https://doi.org/10.1016/j.otohns.2005.08.001 CrossRefPubMedGoogle Scholar
- 8.Sakamoto M, Iikubo M, Kojima I, Sasano T, Mugikura S, Murata T, Watanabe M, Shiga K, Ogawa T, Takahashi S (2014) Diagnostic value of capsule-like rim enhancement on magnetic resonance imaging for distinguishing malignant from benign parotid tumours. Int J Oral Maxillofac Surg 43(9):1035–1041. https://doi.org/10.1016/j.ijom.2014.03.008 CrossRefPubMedGoogle Scholar
- 9.Lechner Goyault J, Riehm S, Neuville A, Gentine A, Veillon F (2011) Interest of diffusion-weighted and gadolinium-enhanced dynamic MR sequences for the diagnosis of parotid gland tumors. J Neuroradiol J Neuroradiol 38(2):77–89. https://doi.org/10.1016/j.neurad.2009.10.005 CrossRefPubMedGoogle Scholar
- 11.Yabuuchi H, Matsuo Y, Kamitani T, Setoguchi T, Okafuji T, Soeda H, Sakai S, Hatakenaka M, Nakashima T, Oda Y, Honda H (2008) Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization? Radiology 249(3):909–916. https://doi.org/10.1148/radiol.2493072045 CrossRefPubMedGoogle Scholar
- 13.Strympl P, Kodaj M, Bakaj T, Kominek P, Starek I, Sisola I, Tomaskova H, Matousek P (2014) Color Doppler ultrasound in the pre-histological determination of the biological character of major salivary gland tumors. Biomedical papers of the Medical Faculty of the University Palacky. Olomouc Czechoslov 158(3):465–469. https://doi.org/10.5507/bp.2012.074 Google Scholar
- 15.Schick S, Steiner E, Gahleitner A, Bohm P, Helbich T, Ba-Ssalamah A, Mostbeck G (1998) Differentiation of benign and malignant tumors of the parotid gland: value of pulsed Doppler and color Doppler sonography. Eur Radiol 8(8):1462–1467. https://doi.org/10.1007/s003300050576 CrossRefPubMedGoogle Scholar
- 19.Davachi B, Imanimoghaddam M, Majidi MR, Sahebalam A, Johari M, Javadian Langaroodi A, Shakeri MT (2014) The efficacy of magnetic resonance imaging and color Doppler ultrasonography in diagnosis of salivary gland tumors. J Dent Res Dent Clin Dent Prospects 8(4):246–251. https://doi.org/10.5681/joddd.2014.044 PubMedPubMedCentralGoogle Scholar
- 22.Habermann CR, Gossrau P, Graessner J, Arndt C, Cramer MC, Reitmeier F, Jaehne M, Adam G (2005) Diffusion-weighted echo-planar MRI: a valuable tool for differentiating primary parotid gland tumors? RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 177(7):940–945. https://doi.org/10.1055/s-2005-858297 CrossRefPubMedGoogle Scholar
- 23.Sumi M, Van Cauteren M, Sumi T, Obara M, Ichikawa Y, Nakamura T (2012) Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors. Radiology 263(3):770–777. https://doi.org/10.1148/radiol.12111248 CrossRefPubMedGoogle Scholar
- 27.Habermann CR, Arndt C, Graessner J, Diestel L, Petersen KU, Reitmeier F, Ussmueller JO, Adam G, Jaehne M (2009) Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? AJNR Am J Neuroradiol 30(3):591–596. https://doi.org/10.3174/ajnr.A1412 CrossRefPubMedGoogle Scholar